120
Participants
Start Date
May 31, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
AYX1 Injection 660 mg / 6 mL
6 mL solution for intrathecal injection with 660 mg of AYX1
AYX1 Injection 1100 mg / 10 mL
10 mL solution for intrathecal injection with 1100 mg of AYX1
Placebo Injection 6 mL
6 mL solution for intrathecal injection; Vehicle formulation designed to mimic AYX1 Injection (with no active drug)
Placebo Injection 10 mL
10 mL solution for intrathecal injection; Vehicle formulation designed to mimic AYX1 Injection (with no active drug)
Sheffield
Phoenix
Adynxx, Inc.
INDUSTRY